Melasma is one of the few skin conditions where sunscreen is not just prevention but treatment, and it is also one of the most demanding. The brown patches respond to long-wave UVA and even visible light, so the protection needs to be broad, high and consistent. That is the standard against which a product called Mela Control Day Cream has to be judged, and it is where this otherwise pleasant, moisturising SPF 32 day cream falls short of its name. The formula has a genuinely interesting filter in it, a nicely rich texture and some calming botanicals, but a PA++ rating and no dedicated brightening active make it an everyday moisturiser with sun protection rather than a melasma product.
The filter system is a hybrid of three. Octinoxate, listed second as ethylhexyl methoxycinnamate, is an established UVB absorber. Titanium dioxide adds physical UVB and short-UVA coverage. The most notable ingredient is bis-ethylhexyloxyphenol methoxyphenyl triazine, better known by its trade name Tinosorb S and its US name bemotrizinol. It is a large, photostable, broad-spectrum filter that has been used in Europe and Asia for more than two decades, and in June 2026 it was added to the US over-the-counter sunscreen monograph, the first new filter permitted there in a generation. It absorbs across UVB and UVA and helps stabilise more fragile filters such as octinoxate, which is exactly why formulators like pairing them.
Why, then, only PA++? The Korean PA grading reflects measured UVA protection, and PA++ corresponds to moderate UVA protection, below the PA+++ and PA++++ grades that most modern daily sunscreens reach. The concentration of Tinosorb S here is not disclosed, and the overall filter load is set to deliver SPF 32 rather than SPF 50. For an office day with limited sun exposure, that is adequate. For melasma, where UVA drives relapses, most clinical advice leans towards higher UVA protection and a tinted formula containing iron oxides to block visible light, neither of which this cream offers.
The name also suggests pigment control from the formula itself, but there is no niacinamide, arbutin, tranexamic acid, azelaic acid or vitamin C derivative in the list. What it has is willow bark, chamomile and Glycyrrhiza inflata extracts, all soothing, with the liquorice root offering some licochalcone A. Bisabolol adds anti-irritant support, and grape seed oil and vitamin E provide antioxidants. These are sensible supporting ingredients, but they are not brightening treatments in their own right. Any melasma improvement from this cream will come from its sun protection, and that protection is moderate.
As a moisturiser, it performs well. Squalane is the third ingredient, and jojoba oil, cetearyl alcohol, cetyl palmitate and C12-15 alkyl benzoate give it a cushioned, lotion-like texture that suits normal to dry skin. The brand calls it a soft lotion type, and it spreads easily, absorbs within a couple of minutes and leaves a comfortable, slightly dewy finish. Oily skin may find it too rich in hot weather. The titanium dioxide is low enough in the list that the white cast is minimal on most skin tones.
The formula also carries fragrance, propylene glycol and two parabens, methyl and ethyl. The parabens are low on the list and considered safe at these levels by regulators, and their presence is more of a preference issue than a safety one. The fragrance is more relevant for this audience, because melasma often coexists with sensitive or reactive skin, and fragrance is one of the most common triggers of irritation and contact allergy.
Using it well means using enough. SPF 32 assumes the standard test amount of two milligrams per square centimetre, which for the face is roughly two finger lengths. A 50 ml tube used at that rate every morning lasts around six weeks. Applying a thin layer of moisturiser-like cream is the most common way day creams underdeliver, and the result can be protection closer to SPF 10 than 30. For outdoor days, a dedicated high-UVA sunscreen and reapplication are better choices.
Reviews in English are limited, as with most of Ciracle's range, so user impressions are scarce. The few available describe a comfortable, moisturising day cream that wears well under makeup, with no strong verdicts on pigmentation.
For someone who does have melasma and likes this texture, there is a workable compromise. Use the cream as the moisturising layer, pair it in the evening with a proven brightening treatment such as azelaic acid, niacinamide or a clinician-recommended option, and on any day with real sun exposure add a tinted, high-UVA sunscreen on top or in its place. That keeps the comfort this cream offers while covering the gaps its ratings leave. Wide-brimmed hats and shade matter too, because no cream fully blocks the visible light that keeps melasma active.
At about twenty-four dollars for 50 ml, the price is reasonable for a moisturiser with SPF and a modern filter like Tinosorb S. It is worth buying if you want a single, comfortable day cream for low-exposure days and appreciate a sophisticated filter. It is less suitable if your main concern is melasma or significant hyperpigmentation, where higher UVA protection, visible-light protection and a separate brightening treatment will do more.
The Mela Control Day Cream is, in the end, a nicely made SPF moisturiser whose most modern ingredient deserves attention and whose name promises more than its ratings can deliver.
